Concepedia

Publication | Open Access

Valganciclovir for Suppression of Human Herpesvirus–8 Replication: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Trial

DOIFull Paper Access

177

Citations

34

References

2008

Year

Corey Casper, Elizabeth M. Krantz, Lawrence Corey, Steven R. Kuntz, Jie Wang, Stacy Selke, Shannon Hamilton, Meei‐Li Huang, Anna Wald
The Journal of Infectious Diseases

Abstract

Valganciclovir administered orally once per day is well tolerated and significantly reduces the frequency and quantity of HHV-8 replication.

References

YearCitations

Page 1